ICD therapy for patients with arrhythmogenic right ventricular dysplasia
Claire Braybrook
This article has no abstract so we have provided the first paragraph of the full text.
Although recent studies have proved that implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death (SCD) in patients with arrhythmogenic right ventricular dysplasia (ARVD), the risk factors for SCD and indications for placement of these devices are not clearly defined. ICDs can be implanted for primary prevention of SCD when patients have a history of syncope or nonsustained ventricular arrhythmia, or for secondary prevention following sustained ventricular arrhythmia.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
